|[June 19, 2014]
BioProcess International (BPI) 2014 takes the Industry's Largest Event to New Heights
BOSTON --(Business Wire)--
IBC Life Sciences, division of Informa (News - Alert), today announced that the 11th
annual BioProcess International (BPI) conference & exhibition will be
held from October 20-23 at the Hynes Convention Center in Boston, MA.
BPI is the largest annual event where all segments involved in the
development and manufacture of biologics gather to network, collaborate
and learn about the most advanced bio-processing methods.
This year's BPI event promises to be the largest and most dynamic
edition yet with more than 1500 delegates from around the world, five
keynotes presentations, 160 speakers, 80+ posters and 150+ exhibitors.
For complete event information visit: http://www.IBCLifeSciences.com/BPI.
"At GE Healthcare we are looking for an understanding of bioprocessing
from start to finish, from cells to formulated drug substance. Going to
BPI we see all of these aspects represented in the program and meet all
those people working across that value chain," said Guenter Jagschies,
Ph.D. Senior Director, Strategic Customer Relations, GE Healthcare Life
Sciences, Sweden. "BPI is an ideal event where our ideas meet
those of our customers and peers."
The conference program covers the full BioProcess spectrum including
upstream processing, downstream processing, formulation and delivery,
manufacturing strategy, analytical and quality and a new early stage
company session on moving quickly from IND to the clinic.
This year's BPI exhibit hall will feature the BPI Theater, designed to
showcase the industry's latest products and innovations. The theater
will host live product demonstrations, panel discussions, rebroadcast
keynote presentations and host live interviews with leading
Featured in the BPI Theater will be companies who are in the forefront
enabling the development of new biological products with new product
launches, including Pall Life Sciences, Meissner Filtration and
Sartorius Stedim Biotech.
Another powerful feature of this year's event is the addition of
partnering360®, the largest online network of life science
dealmakers. Delegates will be granted exclusive access to a BPI specific
partnering360® networking tool that will enable them to
identify and schedule meetings with potential partners, and foster
deeper engagement before, during and following the event.
Significant partnering opportunities exist for biopharmaceutical firms
developing new and improved biologics including mAbs, vaccines, ADCs,
recombinant proteins, bispecifics, enzymes, biosimilars and cell/gene
About IBC Life Sciences
IBC Life Sciences, a division of Informa, is your connection to the life
sciences industry. Through conferences, webinars, podcasts and its suite
of integrated marketing solutions, IBC Life Sciences delivers expert
knowledge, valuable connections and customized offerings so customers
can meet their goals. www.IBCLifeSciences.com
IBC Life Sciences hosts the annual BioProcess International™ (BPI)
Conference and Exhibition. The BioProcess International Conference &
Exhibition is where the biologics value chain meets to do business. Each
year BPI attracts over 1500 biologics industry leaders for four days of
power networking and learning. No other industry event delivers the
high-level connections and insight needed to accelerate your business.
Use this preeminent industry platform to showcase your company, products
and thought leadership. To get involved, visit www.IBCLifeSciences.com/BPI
[ Back To TMCnet.com's Homepage ]